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Apoptosis induced by cisplatin nephrotoxic injury. An agent centration. Uptake of the drug by the renal cells is energy
often used in cancer treatment, cisplatin may cause acute renal and temperature dependent, and it can be inhibited by
failure after even a single dose. Recent laboratory studies con- probenecid, as well as other inhibitors for base transportfirmed the induction of renal cell apoptosis by cisplatin. Reduc-
[2]. Within the cell, cisplatin is found to accumulate intion in cell viability as well as increase in the number of cells
the cytosol, mitochondria, nuclei, and microsomes. Itswith fragmented nuclei correlated with cisplatin exposure in
a dose-dependent manner. Gel electrophoresis revealed the toxic effect is augmented when the intracellular chloride
presence of a characteristic laddering pattern which was pre- concentration is low, which favors the conversion of cis-
ceded by an increase in caspase-3 activity. As the cisplatin con- platin through the replacement of the two chloride li-centration increased beyond 50 mm, the elevation of caspase-3
gands by hydroxyl groups to positively charged reactiveactivity declined, which suggests that necrosis, instead of apopto-
and toxic aquated derivatives [3].sis, is more likely to be responsible for cell death secondary
to higher cisplatin concentrations. Elucidation of the molecular Cisplatin exerts its toxic effects through several differ-
mechanisms of cisplatin nephrotoxicity may lead to the devel- ent mechanisms. The earliest biochemical manifestation
opment of a novel therapeutic strategy that targets cancer cell is the inhibition of protein synthesis, probably throughdeath while simultaneously minimizing renal injury.
the disruption of nucleolus at the site of ribosome synthe-
sis. Alternately, cisplatin may reduce ribosome assembly
through interference of the joining of the 48S and 60SCisplatin, cis-diamminedichloroplatinum II, is an im-
subunits [4]. In addition to the inhibition of protein syn-portant chemotherapeutic agent commonly used for the
thesis, cisplatin may bind with the sulf-hydryl group oftreatment of solid tumors. It is a platinum coordination
reduced glutathione (GSH) and may substantially de-complex with two labile chloride groups. The drug is
crease the availability of GSH to scavenge free reactiveeffective against cancer of the lung, head and neck, testis,
oxygen metabolites. The cisplatin-SH complex may alsoovary, cervix, endometrium, bladder, as well as orophar-
disrupt membrane and enzyme functions and result inynx. Despite the dose dependency of the cisplatin anti-
lipid peroxidation and mitochondrial damage.neoplastic effect, the risk for nephrotoxicity often pre-
Cell death as a result of nephrotoxic injury has alwayscludes the use of higher doses to maximize therapeutic
been thought to result through necrosis. Recently, apop-effect. Renal dysfunction after cisplatin treatment is
tosis has been identified as an alternate mechanism ofcommon, and acute renal failure may develop after expo-
nephrotoxic cell death. The ability of the cell to kill itselfsure to a single dose. Alternately, patients may present
under the appropriate circumstances is important duringwith a chronic condition characterized by polyuria and
development as well as the maintenance of homeostasisrenal electrolyte wasting, especially persistent hypomag-
when the precise numbers of the desirable type of cellsnesemia [1].
have to be controlled. Apoptosis is also the mechanismThe nephrotoxic effect of cisplatin is probably related
through which cells with damaged genetic contents areto its preferential uptake by the proximal tubular cells
removed, which is important to prevent the propagationof the inner cortex and outer medulla, especially in the
of cells with abnormal genes. Many cytotoxic agents haveS3 segment. Other segments of the renal tubule also
been found to cause cell death through both necrosisaccumulate cisplatin, but to a smaller extent. However,
and apoptosis. The specific mechanism of death may bedamage to the non-S3 portions of the tubule may also
related to the concentration, as well as the duration ofcontribute to clinical nephrotoxicity. Cisplatin concen-
exposure to the toxic agents. Cisplatin, as well as manytration in the proximal tubular epithelial cells is five
chemotherapeutic agents, has been recognized to causetimes higher than the corresponding extracellular con-
cancer cell death through apoptosis, and it is of interest
to determine whether apoptosis is also the mechanism of
Key words: nephrotoxicity, cancer treatment, acute renal failure. cell death in nephrotoxic injury [5]. Through an increased
understanding of the specific mechanisms responsible 1999 by the International Society of Nephrology
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layer, chromatin condensation, and nuclei fragmentation.
DNA electrophoresis of cells exposed to high cisplatin
concentrations revealed a “smear pattern.” In contrast,
cells undergoing apoptosis after treatment with low cis-
platin concentrations yielded a “ladder” pattern second-
ary to internucleosomal cleavage of nuclear chromatin
that results in low molecular weight DNA fragments.
These observations indicated that cisplatin can result
in cell death through both necrosis and apoptosis. The
appearance of the specific mechanism is concentration-
dependent. However, further details about the apoptotic
processes associated with cisplatin-induced nephrotoxic
injury have not yet been reported.
The hallmark characteristic of apoptosis is the cleav-
age of nuclear chromatin, through the activation of Ca21
and Mg21 nuclease, to result in low molecular weight
DNA fragments. Although the specific processes in-
volved in the activation of nucleases are not yet known,
it seems that proteolysis is needed before endonucleases
are activated for DNA cleavage. This proteolytic step can
be triggered by the introduction of exogenous proteases,
such as the granzymes found in granules from cytotoxic
lymphocytes. Alternately, internal proteases may be acti-
vated by stimuli such as tumor necrosis factor and Fas
antibodies. Despite the variety of stimuli that can induce
apoptosis, there seems to be a common pathway respon-
sible for the eventual implementation of apoptosis. A
family of intracellular cysteine proteases, the caspases,
is often activated and plays an important role in the
dismantling of cell structures during apoptosis initiated
by both the external and internal pathways. Caspase-1,
also known as interleukin 1b-converting enzyme (ICE),
is a cytoplasmic protease found in monocytes. It cleaves
the interleukin 1b precursor to the mature form, which
is a cytokine that mediates different immune and in-
flammatory responses. Overexpression of caspase-1 can
result in increased apoptosis. Caspase-3, previously
called CPP32/Yama/Apopain, is an ICE-like protein that
when overexpressed can also result in apoptosis. These
Fig. 1. Relationship between the percentage of cell viability and cis-
and other proteases have been studied with much inter-platin exposure with respect to concentration (A) and duration (B).
(A) indicates exposure for 24 hours, and (B) indicates a concentration est because of their role in cleaving different substrates
of 50 mm. that are important in apoptosis.
Our laboratory has recently conducted studies to de-
termine the role of caspase-1 and caspase-3 in cisplatin-
induced renal cell apoptosis. The time course and dosefor nephrotoxic cell injury, strategies can be developed
dependency of cisplatin-induced apoptosis were estab-to minimize or prevent toxicity.
lished by exposing LLC-PK1 cells to different concentra-A study has been completed recently to examine the
tions (30 to 300 mm) of cisplatin over 4 to 48 hours. Cellmechanisms of cell death induced by cisplatin in primary
viability was determined by the CellTiter Aqueous 96culture of mouse tubular cells [6]. High concentrations
Non-radioactive Cell Proliferation Assay Kit (Promega,of cisplatin (800 mm) were found to result in necrotic
Madison, WI, USA). Apoptosis was detected by the pres-cell death, as evidenced by cytosolic swelling and the
ence of condensed or fragmented nuclei as visualizedloss of plasma membrane integrity. In contrast, apoptosis
under fluorescence microscopy after 496-diamidino-2-was observed after exposure to low concentrations (8 mm).
phenylindole (DAPI) staining. DNA fragmentation wasThe cells demonstrated the hallmark characteristics of
apoptosis: cell shrinkage, loss of attachment to mono- confirmed by the presence of a typical ladder pattern
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Fig. 3. Relationship between caspase-1 (j) and caspase-3 (r) activities
after exposure to 50 mM cisplatin over different time periods.
Fig. 2. Gel electrophoresis of LLC-PK1 cells after cisplatin treatment
for up to 48 hours.
during gel electrophoresis. Caspase activity was deter-
mined by a fluorogenic assay. A dose-dependent rela-
tionship was observed between the percentage of cell
viability and the doses of cisplatin, as well as the duration
of drug exposure (Fig. 1). The number of cells with frag-
mented nuclei increased from 9 to 39% as the time of
exposure to 50 mm cisplatin increased from 8 to 24 hours.
Fig. 4. Relationship between caspase-3 activities after exposure to dif-
DNA fragmentation, as evidenced by the presence of a ferent concentrations of cisplatin for 12 hours.
laddering pattern, began to appear after 12 hours of
exposure to 50 mm cisplatin (Fig. 2). There was no change
in caspase-1 activity after cisplatin treatment; however,
caspase-3 activity increased by approximately twofold dependent increase in caspase-3 activity induction be-
tween 15 and 50 mm of cisplatin (Fig. 4). However, theafter six hours of exposure to 50 mm cisplatin (Fig. 3).
This was increased to 35-fold after 24 hours of cisplatin induced caspase-3 activities began to decline as the cis-
platin concentration was increased beyond 50 mm. Thesetreatment. The relationship between cisplatin dose and
caspase-3 activity induction was also evaluated. After data indicate that cisplatin treatment results in an increase
of caspase-3, but not caspase-1 activity. The increase inexposure to cisplatin for 12 hours, there was a dose-
Lau: Apoptosis induced by cisplatin nephrotoxic injury1298
caspase-3 activity, which preceded the appearance of in preventing the induction of an immune response to-
ward the intracellular proteins when they are releasedDNA fragmentation, suggests that the enzyme may play
after cell disintegration.an important role in the implementation of apoptosis.
Information available thus far indicates that apoptosisAs the induced caspase-3 activity began to decline after
does play a role in cisplatin-induced nephrotoxic renalattaining maximum induction at 50 mm of cisplatin, it
injury. However, details of the specific mechanisms andsuggests that necrosis, instead of apoptosis, might be
their interrelationships are far from clearly understood.responsible for cell death after treatment with higher
Knowledge of the significance of apoptosis after theconcentrations of cisplatin.
nephrotoxic injury opens up many opportunities to mod-As the concentrations of caspases and other proteases
ulate these intricate processes. Further studies areincrease during apoptosis, the enzymes act on different
needed to acquire an increased appreciation of the manyprotein targets. However, the specific targets of the dif-
different participants of the apoptotic process and theirferent proteases have not been elucidated. Poly(ADP-
significance. Based on the new understanding of the mo-ribose) polymerase (PARP), which plays an important
lecular mechanisms of cisplatin-induced apoptosis, newrole in the repair of damaged DNA, is a likely target
strategies can be developed to prevent renal cell injuryfor the ICE-like proteases. Inactivation of PARP by
or to enhance recovery after cisplatin treatment.proteases would result in increased apoptosis. Caspase-3
is a precursor of the protease responsible for cleaving Reprint requests to Dr. Alan Lau, Department of Pharmacy Practice,
College of Pharmacy, University of Illinois at Chicago, 833 South WoodPARP. It is cleaved and activated by granzyme B, a
Street, Room #164 (m/c886), Chicago, Illinois 60612, USA.
protease from cytotoxic T cell, which has the ability to
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